Leuprolide Acetate Kit
Product Images NDC 0121-2106

Product Visual Gallery

This gallery contains 16 technical images submitted to the FDA as part of the official labeling for Leuprolide Acetate (NDC 0121-2106). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pai Holdings, Llc Dba Pai Pharma, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Leuprolide_injection_structure (Leuprolide Acetate Injection 1)

Chemical structure of leuprolide acetate, illustrating the molecular composition and bonding arrangement of the active ingredient in the drug.*

FDA Label Image

Leuprolide Injection (Figure I)

An instructional illustration showing two hands preparing a syringe by drawing liquid from a vial, likely demonstrating the steps to prepare a subcutaneous injection. The vial is held upside down while the syringe needle is inserted to withdraw the medication.*

FDA Label Image

Lueprolide Injection (Figure J)

An instructional illustration showing two hands administering a subcutaneous injection with a syringe. One hand holds the syringe vertically while the other hand gently pinches the skin at the injection site.*

FDA Label Image

Lueprolide Injection (Figure K)

An instructional illustration depicting the use of a syringe to administer a subcutaneous injection. The image shows one hand holding the syringe inserted at an angle into the skin, while the other hand holds the skin taut, with an arrow indicating upward movement of the syringe plunger.*

FDA Label Image

Lueprolide Injection (Disposal)

A black and white instructional illustration showing a hand disposing of a syringe or needle into a labeled sharps container designed for safe medical waste disposal.*

FDA Label Image

Multi-dose Vial Label (Leuprolide Acetate Injection 14)

Leuprolide Acetate Injection 14 mg/2.8 mL multi-dose vial label for subcutaneous injection. The label shows dosage strength, manufacturer PAI Pharma, lot number, expiration date, storage instructions, and usage warnings. It is marked as Rx only.*

FDA Label Image

Multi-dose Carton (Leuprolide Acetate Injection 15)

Leuprolide Acetate Injection 14 mg/2.8 mL (1 mg/0.2 mL) sterile multi-dose vial carton by PAI Holdings, LLC dba PAI Pharma. The label includes dosing instructions for subcutaneous injection, storage conditions, ingredient details, and distribution information. The product is prescription-only and intended for subcutaneous administration.*

FDA Label Image

Kits_carton-2106 (Leuprolide Acetate Injection 16)

The packaging label for Leuprolide Acetate Injection 14 mg/2.8 mL (1 mg/0.2 mL), a 14-day patient administration kit by PAI Holdings, LLC dba PAI Pharma. The kit is intended for subcutaneous injection and includes 2.8 mL vial of leuprolide acetate, a 14-day patient administration kit, a needle, syringes, and instructions. Storage instructions state to keep the vial below 25°C (77°F) and protect from light.*

FDA Label Image

Figure A (Image)

A black and white instructional illustration showing a hand holding a syringe with measurement markings, suggesting a subcutaneous injection technique. The syringe is positioned near the skin, indicating preparation for injection.*

FDA Label Image

Figure B (Image)

An instructional black and white line drawing showing a pair of hands washing under a running faucet. This image likely demonstrates proper hand hygiene technique prior to administering a subcutaneous injection.*

FDA Label Image

Figure C (Image)

An instructional black-and-white illustration showing a hand holding a vial cap with a flip-top design, demonstrating how to open or access the medication inside the vial. The image focuses on the cap removal process, typical for preparing subcutaneous injection kits.*

FDA Label Image

Figure D (Images)

An instructional illustration showing a close-up of two hands handling a small vial or container, likely demonstrating preparation or administration steps for a subcutaneous drug kit.*

FDA Label Image

Lueprolide Injection (Figure E)

An instructional illustration showing a hand holding a syringe with an arrow indicating the direction to push the plunger. This diagram appears to demonstrate proper syringe use, such as administration or preparation technique, related to a subcutaneous injection.*

FDA Label Image

Leuprolide Injection (Figure F)

A black and white instructional illustration depicting a hand holding a vial and another hand holding a syringe with a needle, showing the process of drawing liquid from the vial into the syringe. No text or branding is visible in the image.*

FDA Label Image

Lueprolide Injection (Figure G)

Black and white instructional illustration showing a hand holding a vial and another hand pulling fluid into a syringe, depicting preparation of a subcutaneous injection kit for leuprolide acetate.*

FDA Label Image

Lueprolide Injection (Figure H)

Black-and-white instructional illustration showing a close-up of hands preparing a syringe by attaching it to a vial or cartridge, likely demonstrating the proper connection technique for a subcutaneous injection kit.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.